Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01373177
Other study ID # 10-007937
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 2011
Est. completion date February 2015

Study information

Verified date November 2019
Source Children's Hospital of Philadelphia
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The objective of this randomized study is to test the hypothesis that scores on the Bayley Scales of Infant Development-III (Bayley-III) are higher than scores on the Bayley Scales of Infant Development-II (BSID-II) in the same group of infants who were born very preterm.


Description:

The objective of this randomized crossover study is to test the hypothesis that scores on the Bayley Scales of Infant Development-III are higher than scores on the Bayley Scales of Infant Development-II in the same group of infants who were born very preterm. First, however, the investigators must demonstrate that significant "learning" does not occur when the tests are administered 4-8 weeks apart. The investigators hypothesize that scores on the Bayley-III will be higher than scores on the BSID-II, irrespective of the order in which the tests are administered.


Recruitment information / eligibility

Status Completed
Enrollment 119
Est. completion date February 2015
Est. primary completion date February 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Months to 22 Months
Eligibility Inclusion Criteria:

- Birth weight <2000 grams and <32 weeks

- Corrected age of 18-22 months.

Exclusion Criteria:

- English is not the primary language in the child's home.

- Parent is unable to give informed consent for research participation.

- Parent is unable to commit to returning for follow-up testing in 4-8 weeks.

- Infant has severe medical illness or disability expected to impact his/her ability to participate in testing (ex: blindness, deafness, severe cerebral palsy, autism, tracheostomy).

- No exclusion for economic status, gender, race or ethnicity.

- Participation in a RCT that restricts timing and administration of developmental testing.

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Bayley Scales of Infant Development-II
Individually administered test, designed to evaluate the developmental functioning of infants and small children, between 1 and 42 months of age. The purpose of the test is to identify infants and children with developmental delay. BSID-II was published in 1993. BSID-II provides normative data from two scales - Mental Development Index (MDI), and Psychomotor Development Index (PDI).
Bayley Scales of Infant Development-III
Individually administered test, designed to evaluate the developmental functioning of infants and small children, between 1 and 42 months of age. The purpose of the test is to identify infants and children with developmental delay. BSID-III was released in 2006. BSID-III provides normative data from five scales - Cognitive, Language, Motor, Social-Emotional, and Adaptive.

Locations

Country Name City State
United States The Children's Hospital of Philadelphia Philadelphia Pennsylvania

Sponsors (2)

Lead Sponsor Collaborator
Children's Hospital of Philadelphia University of Pennsylvania

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary The primary outcome is the mean difference between BSID-II Mental Development Index (MDI) and Bayley-III Cognitive Score. 18-22 months
Secondary Mean difference between BSID-II Physical Development Index and Bayley-III Composite Motor Score. 18-22 months
Secondary Proportion of infants classified as having "developmental delay" (MDI <70 on BSID-II or either Language or Cognitive Score <70 on the Bayley-III). 18-22 months
Secondary The mean difference in scores between time point one and time point two (a measure of learning or training). 18-22 months
See also
  Status Clinical Trial Phase
Recruiting NCT05793112 - INF108F in Infants With Food Protein Induced Proctocolitis Phase 4
Recruiting NCT03828708 - Early Iron Exposure on the Gut Microbiota in Young Infants N/A
Recruiting NCT06018064 - Investigating Fit and Satisfaction of the Prone Positioner N/A
Not yet recruiting NCT06335524 - Infant-Maternal Partnership and Cognitive Training Study for Preterm Infants N/A
Not yet recruiting NCT05039918 - Neonatal Experience of Social Touch N/A
Completed NCT01166867 - A Pilot Study Using Photo-plethysmographic (PPG) Camera
Completed NCT00791466 - Maternal Iodine Supplementation and Effects on Thyroid Function and Child Development N/A
Completed NCT03331276 - Growth and Safety Study of an Infant Formula for Healthy Term Infants N/A
Completed NCT05157633 - Oral Exploration of Objects and Food Diversification
Completed NCT05217186 - Associations Between Early Neonatal Neuroimaging, Hammersmith Infant Neurological Examination and General Movements
Recruiting NCT05006989 - Blueberry Intake and Infant Gut Health N/A
Completed NCT04901611 - Parental Touch Trial (Petal) N/A
Completed NCT03082313 - Movement-based Infant Intervention N/A
Recruiting NCT06053515 - Rosie the Chatbot: Leveraging Automated and Personalized Health Information Communication N/A
Completed NCT05394883 - The SPROUT (Pilot) Project N/A
Completed NCT03991949 - Evaluation of Preterm Infants Fed Post-Discharge Preterm Infant Formula N/A
Active, not recruiting NCT03851120 - Brain Probiotic and LC-PUFA Intervention for Optimum Early Life Phase 2
Completed NCT03662048 - Improving Infant Sleep Safety With the Electronic Health Record N/A
Active, not recruiting NCT04749888 - Impact of the Korea Early Childhood Home-visiting Intervention N/A
Recruiting NCT06230848 - Multisensory Early Oral Administration of Human Milk in Preterm Infants N/A